MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SARTORELLI, A. C.
Right arrow Articles by TSUNAMURA, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SARTORELLI, A. C.
Right arrow Articles by TSUNAMURA, S.

Molecular Pharmacology, Vol 2, 275-283, Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics

Studies on the Biochemical Mode of Action of a Cytotoxic Methylhydrazine Derivative, N-Isopropyl-agr-(2-methylhydrazino)-p-toluamide

ALAN C. SARTORELLI 1 and SHIRO TSUNAMURA 1

1 Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut

N-Isopropyl-agr-(2-methylhydrazino)-p-toluamide inhibited the incorporation of thymidine-3H, deoxycytidine-3H, formate-14C, adenine-8-14C, and 4-amino-5-imidazolecarboxamide-2-14C into DNA, and the utilization of orotic acid-6-14C and leucine-1-14C for the synthesis of RNA and protein, respectively, in L5178Y lymphoma cells. The site of the drug-induced blockade of the formation of DNA did not appear to reside at the level of thymidine kinase (ATP:thymidine 5'-phosphotransferase, EC 2.7.1.21), thymidine monophosphate kinase (ATP:thymidine monophosphate phosphotransferase, EC 2.7.4.9), or DNA nucleotidyltransferase (deoxynucleosidetriphosphate:DNA deoxynucleotidyltransferase, EC 2.7.7.7). Furthermore, treatment of cells with N-isopropyl-agr-(2-methylhydrazino)-p-toluamide did not influence the rate of loss of thymine-3H from prelabeled DNA. Possible metabolic alterations which might explain the observed results are discussed. The inhibitions of the syntheses of nucleic acids and proteins that were measured were followed by a period during which most of the cell death occurred; this period corresponded with the development of a metabolic imbalance that was characterized by an accumulation of RNA and protein and an increase in cell volume.

Note:
ACKNOWLEDGMENTS The authors wish to thank Dr. W. E. Scott, Hoffmann-La Roche, Inc. for a generous supply of MIH and Miss Sheila J. Feld for excellent technical assistance. This investigation was supported by USPHS Research Grant CA-02817 from the National Cancer Institute and by Grants ACS IN-31E-806 and ACS IN-31F-905 from the American Cancer Society. One of us (S.T.) gratefully acknowledges postdoctoral support from the Anna Fuller Fund.

Submitted on February 21, 1966







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics